Metallothionein<i>MT2A</i>A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies
Yuta Hattori(Nagoya University), Kenji Wakai(Japanese Society for Dialysis Therapy), Rieko Okada(Nagoya City University), Tae Sasakabe(Nagoya University), Sahoko Takagi(Nagoya University), Masahiro Nakatochi(Nagoya University), Nobuyuki Hamajima(Nagoya University), Masahiko Satoh(Aichi Gakuin University), Asahi Hishida(Nagoya City University), Takashi Matsunaga(Shiga University of Medical Science), Hisao Naito(Kinjo Gakuin University), Sayo Kawai(Nagoya University), Shino Suma(Nagoya University), Mariko Naito(Nagoya City University), Masashi Kato(Nagoya University), Toshio Seiki(Nagoya University)
Cited by 32
Related Papers
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|438
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425